Discover trends, market shifts, and competitive outlooks for the biomarkers industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Biomarkers Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The size of the biomarkers market has seen a fast-paced expansion lately. The market which was valued at $68.77 billion in 2024, is predicted to advance to $78.14 billion by 2025, with a compound annual growth rate (CAGR) of 13.6%. This swift growth in the historic period is a result of advancements in the fields of genomics and proteomics, a surge in chronic disease prevalence, heightened focus on individualized medicine, increased need for companion diagnostics, and the broadening of applications in pharmaceutical development.

In the ensuing years, a fast expansion is anticipated in the biomarkers market, with its value projected to escalate to $135.14 billion in 2029, experiencing a compound annual growth rate (CAGR) of 14.7%. Factors such as the emphasis on early disease detection and prevention, the inclining utility of biomarkers in oncology and immunotherapy, growth in investment in precision medicine initiatives, the emergence of liquid biopsy as a non-aggressive method for biomarker detection, and the increased usage of biomarkers in drug discovery and development are significantly contributing to this growth for the forecasted period. Key trends anticipated during this timeframe include the progression of multi-biomarker panels, the rise of exosome-based biomarkers, the adoption of point-of-care biomarker testing, the integration of real-world data in biomarker research, and the exploration of microbiome-based biomarkers.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Biomarkers Market?

The escalation in heart-related illnesses in the future is predicted to spur the development of the biomarkers market. The adoption of biomarkers for heart patients has witnessed a significant rise in recent years. At present, natriuretic peptides, a type of biomarker, find extensive use and aid in diagnosing heart failure. Circulating biomarkers exhibiting high sensitivity C-reactive protein are employed for heart failure diagnosis. Heart disease stands as a major reason behind mortality among diverse racial and ethnic groups in the United States. The surge in heart diseases will subsequently enhance the demand for biomarkers. As revealed by a report released by the American College of Cardiology, US-based non-profit medical association, in August 2022, there is an expected rise across all four cardiovascular risk factors in America between 2025 and 2060. Diabetes is anticipated to witness the highest percentage surge, with a projected 39.3% increase, affecting up to 55 million individuals. This is followed by dyslipidemia (27.6% impacting 126 million), hypertension (25.1% affecting 162 million), and obesity (18.3% affecting 126 million). The study further noted that the most significant predicted rises in cardiovascular disease rates were stroke (33.8% affecting 15 million) and heart failure (33.4% affecting 13 million), followed by ischemic heart disease (30. 7% affecting 29 million) and heart attack (16.9% affecting 16 million). Owing to the surge in heart diseases and associated mortalities, biomarkers will see an upswing in growth.

Which Primary Segments of the Biomarkers Market Are Driving Growth and Industry Transformations?

The biomarkers market covered in this report is segmented –

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6485&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Biomarkers Market?# Market?

North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Biomarkers Market?

Key players in the biomarker industry are concentrating on creating cutting-edge solutions like innovative biological markers to foster innovation via joint scientific research, incorporation of technology, and extensive clinical validation. A newly recognized sign that mirrors biological activities, the innovative biological marker aids in disease diagnosis or tracking. It could be a molecule, gene, or cellular attribute with potential benefits for individualized medicine. For example, in September 2024, Genialis, a leading American computational precision medicine company, introduced a pioneering biomarker. This first-of-its-kind biomarker improves forecasting accuracy for patient responses to KRAS inhibitors, allowing for tailored treatment strategies and better clinical outcomes. Furthermore, its wide applicability across various cancer forms enhances efficient drug creation and refines patient selection for target-specific therapies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

What Parameters Are Used to Define the Biomarkers Market?

Biomarkers refer to a biological molecule that is a marker for a condition, disease, or aberrant process and can be discovered in tissues, body fluids, or blood. It is used to determine how well the body responds to a disease or condition’s treatment. These biomarkers have a clinical role in narrowing or guiding treatment decisions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model